Analysen von Richard Vosser
| 14.07.17 | Roche overweight | JP Morgan Chase & Co. | |
| 12.07.17 | Roche overweight | JP Morgan Chase & Co. | |
| 11.07.17 | Roche overweight | JP Morgan Chase & Co. | |
| 03.07.17 | Bayer overweight | JP Morgan Chase & Co. | |
| 30.06.17 | Roche overweight | JP Morgan Chase & Co. | |
| 27.06.17 | Roche overweight | JP Morgan Chase & Co. | |
| 07.06.17 | Roche overweight | JP Morgan Chase & Co. | |
| 18.05.17 | Roche overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 03.05.17 | Roche overweight | JP Morgan Chase & Co. | |
| 19.04.17 | Bayer overweight | JP Morgan Chase & Co. | |
| 18.04.17 | Roche overweight | JP Morgan Chase & Co. | |
| 04.04.17 | Bayer overweight | JP Morgan Chase & Co. | |
| 03.04.17 | Roche overweight | JP Morgan Chase & Co. | |
| 30.03.17 | Roche overweight | JP Morgan Chase & Co. | |
| 16.03.17 | Bayer overweight | JP Morgan Chase & Co. | |
| 03.03.17 | Roche overweight | JP Morgan Chase & Co. | |
| 02.03.17 | Bayer overweight | JP Morgan Chase & Co. | |
| 23.02.17 | Bayer overweight | JP Morgan Chase & Co. | |
| 15.02.17 | Roche overweight | JP Morgan Chase & Co. | |
| 13.02.17 | Bayer overweight | JP Morgan Chase & Co. | |
| 09.02.17 | Bayer overweight | JP Morgan Chase & Co. | |
| 02.02.17 | Roche overweight | JP Morgan Chase & Co. | |
| 23.01.17 | Roche overweight | JP Morgan Chase & Co. | |
| 12.01.17 | Roche overweight | JP Morgan Chase & Co. | |
| 12.01.17 | Bayer overweight | JP Morgan Chase & Co. | |
| 03.01.17 | Roche overweight | JP Morgan Chase & Co. | |
| 03.01.17 | Bayer overweight | JP Morgan Chase & Co. | |
| 13.12.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 06.12.16 | Roche overweight | JP Morgan Chase & Co. | |
| 29.11.16 | Roche overweight | JP Morgan Chase & Co. | |
| 18.11.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 26.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 10.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 10.10.16 | Roche overweight | JP Morgan Chase & Co. | |
| 07.10.16 | Roche overweight | JP Morgan Chase & Co. | |
| 29.09.16 | Roche overweight | JP Morgan Chase & Co. | |
| 13.09.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 02.09.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.08.16 | Roche overweight | JP Morgan Chase & Co. | |
| 03.08.16 | Roche overweight | JP Morgan Chase & Co. | |
| 22.07.16 | Roche overweight | JP Morgan Chase & Co. | |
| 21.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 20.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.07.16 | Roche overweight | JP Morgan Chase & Co. | |
| 18.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 13.07.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 11.07.16 | Roche overweight | JP Morgan Chase & Co. | |